Publications by authors named "Basak Ayık"
Aim: The aim of this study was to determine the prevalence of childhood psychopathologies in Turkey.
Method: A nation-wide, randomly selected, representative population of 5830 children (6-13 years-old) enrolled as a 2nd,3rd or 4th grade student in 30 cities were evaluated for presence of a psychiatric or mental disorder by a Sociodemographic Form, Kiddie Schedule for Affective Disorders and Schizophrenia for School Age Children-Present and Lifetime Version (K-SADS-PL), and DSM-IV-Based Screening Scale for Disruptive Behavior Disorders in Children and Adolescents scales. Impairment criterion was assessed via a 3 point-Likert scale by the parent and the teacher independently.
Article Synopsis
- The study aimed to assess the prevalence of affective disorders in a representative sample of Turkish students from second to fourth grades.
- A total of 5,842 participants were analyzed, revealing a 2.5% prevalence of affective disorders, with major depressive disorder (MDD) being the most common at 1.06%.
- The findings suggest the need for early interventions, particularly for children with family risk factors like maternal psychopathology and paternal illness.
Background: There is controversial information on outcome of school age individuals who lose the diagnosis of autism and achieve "optimal outcome" (OO). The present study assessed the autism symptoms and other psychiatric disorders in a group of children with a past history of autism.
Methods: The subjects consisted of 26 individuals who had lost the diagnosis of autism 2-8 years previously.
Objective: The aim of this retrospective study is to examine the clinical outcomes and safety of clozapine in children and adolescents with schizophrenia or other psychotic disorders/autism spectrum disorder (ASD) or affective disorders.
Methods: The inpatient and outpatient files of all children and adolescents treated with clozapine over a period of 34 months (from October 2011 to July 2014) were reviewed. Demographic and clinical data were examined to describe clinical and metabolic findings, dosing, and tolerability of clozapine treatment in youth with schizophrenia, other psychotic disorders, ASD, or bipolar disorder.